SMBC Nikko analyst David Dai downgrades Jounce Therapeutics (NASDAQ:JNCE) from Outperform to Neutral.
How Zoom Communication’s Stock Looks Heading Into Q4 Earnings: Charting The Path Ahead
Zoom Video Communications, Inc (NASDAQ: ZM) was trading up about 5% at one point on Monday, as the company headed into its fourth-quarter earnings print after the market close.